Displaying 2081 - 2100 of 2478
ValueAct Partners, LP, United States of America (for the FTC)
In December 2007, the Commission challenged ValueAct Capital Partners’ violations of the Hart-Scott-Rodino Pre-Merger Notification Act’s filing requirements related to the acquisition of stock in three companies, Gartner, Inc., Catalina marketing Group, and Acxiom Corp. The firm previously violated the HSR filing requirements in 2003, and after making corrective filings, and agreeing to put HSR safeguards into place to ensure compliance with the filing requirements, the Commission decided to take no action. However, ValueAct failed to enact the necessary preventative measures and again violated the HSR filing requirements with its aforementioned acquisitions resulting in the Commission seeking civil penalties in the amount of $1.1 million.
New Mexico Court Temporarily Blocks Western Refinings Acquisition of Rival Energy Company Giant Industries, Inc.
Energy Markets in the 21st Century: Competition Policy in Perspective
FTC Seeks to Block Western Refinings Proposed Acquisition of Giant Industries
FTC Issues FY 2006 FDCPA Report to Congress; Commission Approves Filing of Amended Complaint in Matter of Global Marketing Group, Inc.; FTC Approves Federal Register Notice on Recycled Oil Rule; FTC Approves Federal Register Notice on Agency Systems of
FTC Sues to Block Acquisition of The Peoples Natural Gas Company from Dominion Resources
Missouri Funeral Regulators Agree to Settle FTC Antitrust Charges
FTC Provides U.S. Senate with Overview of Recent Antitrust Activities
FTC Testifies on Patent Reform Recommendations
Broadband Connectivity Competition Policy
MiRealSource Settles Charges it Illegally Restrained Competition
FTC Issues Updated Horizontal Merger Investigation Data Report
FTC Challenges Acquisition of Interests in Kinder Morgan, Inc. by The Carlyle Group and Riverstone Holdings
FTC Challenges Hospira/Mayne Pharma Deal
Bureau of Competition Issues FY 2006 Summary of Pharmaceutical Company Settlement Agreements
FTC Provides Senate Testimony on Anticompetitive Patent Settlements in the U.S. Pharmaceutical Industry
Displaying 2081 - 2100 of 2478